Latest Breaking News On - Lynda mitchell - Page 1 : comparemela.com

Pulmonology Month in Review: April 2024

In this review of April 2024, the editorial team highlighted some of the biggest stories in the pulmonary health space, touching on topics such as air quality issues, asthma, and pneumonia.

Allergy advocacy organizations disappointed by updated USDA WIC guidelines

Benralizumab Receives FDA Approval as Add-On Maintenance Therapy for Asthma

The FDA approval of benralizumab for patients ages 6 to 11 with asthma follows the conclusions of the phase 3 TATE study.

FDA Approves Benralizumab to Treat Pediatric Patients Aged 6 to 11 Years With Severe Asthma

Benralizumab was previously approved by the FDA in 2017 as an add-on maintenance therapy for patients 12 years and older.

FASENRA approved for treatment of children aged 6 to 11 with severe asthma

Additional indication for pediatric patients with severe eosinophilic asthma .